about
Enhanced effects of TRAIL-endostatin-based double-gene-radiotherapy on suppressing growth, promoting apoptosis and inducing cell cycle arrest in vascular endothelial cells.Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Current status of tumor radiogenic therapy.
@ast
Current status of tumor radiogenic therapy.
@en
type
label
Current status of tumor radiogenic therapy.
@ast
Current status of tumor radiogenic therapy.
@en
prefLabel
Current status of tumor radiogenic therapy.
@ast
Current status of tumor radiogenic therapy.
@en
P2093
P2860
P356
P1476
Current status of tumor radiogenic therapy.
@en
P2093
Feng-Ling Min
Hong Zhang
Wen-Jian Li
P2860
P304
P356
10.3748/WJG.V11.I20.3014
P407
P577
2005-05-01T00:00:00Z